(R)-(-)-4-(1H-INDOL-3-YLMETHYL)-2-OXAZOLIDINONE
98%
- Product Code: 70253
CAS:
157636-81-2
| Molecular Weight: | 216.2359 g./mol | Molecular Formula: | C₁₂H₁₂N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD01863583 | |
| Melting Point: | 157-160 °C(lit.) | Boiling Point: | 544.4 °C at 760 mmHg |
| Density: | 1.326 g/cm3 | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the production of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure is often incorporated into the design of inhibitors for specific enzymes or receptors in the central nervous system. Additionally, it is used in the development of chiral compounds, where its stereochemistry plays a crucial role in enhancing the efficacy and selectivity of therapeutic agents. Researchers also explore its potential in creating novel drug candidates with improved pharmacokinetic properties.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to yellow powder or crystals |
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | £73.73 |
+
-
|
(R)-(-)-4-(1H-INDOL-3-YLMETHYL)-2-OXAZOLIDINONE
This compound is primarily utilized in the field of organic synthesis and pharmaceutical research. It serves as a key intermediate in the production of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure is often incorporated into the design of inhibitors for specific enzymes or receptors in the central nervous system. Additionally, it is used in the development of chiral compounds, where its stereochemistry plays a crucial role in enhancing the efficacy and selectivity of therapeutic agents. Researchers also explore its potential in creating novel drug candidates with improved pharmacokinetic properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :